Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia

Atherosclerosis

Volumn 137, Issue 1, 1998, Pages 197-203

  Simons, L A ^a   Sullivan, D ^b   Simons, J ^a   Celermajer, D S ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Atorvastatin; Endothelial dysfunction; Flow mediated dilatation; Hypercholesterolaemia; Simvastatin; Vascular ultrasound

Indexed keywords

ATORVASTATIN; COLESTYRAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SIMVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTICHOLESTEREMIC AGENTS; ARTHRALGIA; BRACHIAL ARTERY; CHOLESTYRAMINE; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; EXANTHEMA; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; PYRROLES; SIMVASTATIN; TREATMENT OUTCOME;

EID: 0032478236     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00252-9     Document Type: Article

References (39)

1. Henderson AH Endothelium in control. Br Heart J. 65:1991;116-125.
2. Boger RH, Bode-Boger SM, Frolich JC The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications. Atherosclerosis. 127:1996;1-11.
3. Ludmer PL, Selwyn AP, Shook TL et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. New Engl J Med. 315:1986;1046-1051.
4. Vita JA, Treasure CB, Nabel EG et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
5. Celermajer DS, Sorensen KE, Georgakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilatation in healthy young adults. Circulation. 88:1993;2149-2155.
6. Panza JA, Quyyumi AA, Callahan TS, Epstein SE Effect of anti-hypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 21:1993;1145-1151.
7. Leung WH, Lau CP, Wong CK Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 341:1993;1496-1500.
8. Egashira K, Hirooka Y, Kai H Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 89:1994;2519-2524.
9. Anderson TJ, Meredith IT, Yeung AC The effect of cholesterol-lowering and anti-oxidant therapy on endothelium-dependent coronary vasomotion. New Engl J Med. 332:1995;488-493.
10. Treasure CB, Klein JL, Weintraub WS et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. New Engl J Med. 332:1995;481-487.
11. O'Driscoll G, Green D, Taylor RR Simvastatin, an HMG-Coenzyme A reductase inhibitor, improves endothelial function in 1 month. Circulation. 95:1997;1126-1131.
12. Levine GN, Frei B, Koulouris SN et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 93:1996;1107-1113.
13. McCrohon JA, Adams MR, McCredie RJ et al. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women. Clin Endocrinol. 45:1996;435-441.
14. Mancini GBJ, Henry GC, Macaya C et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 94:1996;258-265.
15. Celermajer DS, Sorensen KE, Gooch VM et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
16. Anderson TJ, Uehata A, Gerhard MD et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
17. Lieberman EH, Gerhard MD, Uehata A et al. Flow-induced dilatation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. Am J Cardiol. 78:1996;1210-1214.
18. Nawrocki JW, Weiss SR, Davidson MH et al. Reduction of LDL cholesterol by 25-60% in patients with primary hypercholeserolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol. 15:1995;678-682.
19. Bakker-Arkema RG, Davidson MH, Goldstein RJ et al. Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia. J Am Med Assoc. 275:1996;128-133.
20. Bertolini S, Bon GBB, Campbell LM et al. Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia. Atherosclerosis. 130:1997;191-197.
21. Allain CC, Poon LC, Chan CSG et al. Enzymatic determination of total serum cholesterol. Clin Chem. 20:1974;470-475.
22. Bucolo G, David H Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 19:1973;476-482.
23. Burstein M, Scholnick HR, Morfin R Rapid methods for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res. 11:1970;583-595.
24. Friedewald WT, Levy RI, Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
25. Sorensen KE, Celermajer DS, Spiegelhalter DJ et al. Non-invasive measurement of human endothelium-dependent arterial responses: accuracy and reproducibility. Br Heart J. 74:1995;247-253.
26. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
27. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. New Engl J Med. 333:1995;1301-1306.
28. Simons LA, Simons J, Parfitt A Successful management of primary hypercholesterolaemia with simvastatin and low-dose colestipol. Med J Aust. 157:1992;455-459.
29. Neunteufl T, Katzenschlager R, Hassan A et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis. 129:1997;111-118.
30. Celermajer DS, Adams MR, Clarkson P et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. New Engl J Med. 334:1996;150-154.
31. Sorensen KE, Celermajer DS, Georgakopoulos D et al. Impairment of endothelium-dependent dilatation is an early event in children with familial hypercholesterolemia, and is related to the Lp(a) level. J Clin Invest. 93:1994;50-55.
32. Celermajer DS, Sorensen KE, Spiegelhalter DJ et al. Ageing is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol. 24:1994;471-476.
33. Vogel RA, Corretti MC, Plotnick GD Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men. Am J Cardiol. 77:1996;37-40.
34. Blankenhorn DH, Azen SP, Kramsch DM et al. Coronary angiographic changes with lovastatin therapy. Ann Intern Med. 119:1993;969-976.
35. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 346:1995;467-471.
36. Tamai O, Matsuoka H, Itabe H et al. Single LDL apheresis improves endothelium-dependant vasodilatation in hypercholesterolemic humans. Circulation. 95:1997;76-82.
37. Joannides R, Haefeli WE, Linder L et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314-1319.
38. Ohara Y, Peterson TE, Harrison DG Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
39. Andrews TC, Raby K, Barry J et al. Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease. Circulation. 95:1997;324-328.